EyePoint, Inc. (EYPT)
0.4052
-0.03
(-7.91%)
USD |
NASDAQ |
Oct 20, 16:00
0.4106
+0.01
(+1.33%)
After-Hours: 07:09
EyePoint Gross Profit (TTM) : -0.51M for June 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.51M |
| March 31, 2026 | 4.303M |
| December 31, 2025 | 28.42M |
| September 30, 2025 | 39.30M |
| June 30, 2025 | 48.84M |
| March 31, 2025 | 52.28M |
| December 31, 2024 | 39.56M |
| September 30, 2024 | 41.82M |
| June 30, 2024 | 46.03M |
| March 31, 2024 | 45.27M |
| December 31, 2023 | 41.39M |
| September 30, 2023 | 35.27M |
| June 30, 2023 | 29.27M |
| March 31, 2023 | 31.17M |
| December 31, 2022 | 31.03M |
| September 30, 2022 | 32.01M |
| June 30, 2022 | 30.63M |
| March 31, 2022 | 27.89M |
| December 31, 2021 | 26.30M |
| September 30, 2021 | 22.46M |
| June 30, 2021 | 29.04M |
| March 31, 2021 | 25.58M |
| December 31, 2020 | 26.15M |
| September 30, 2020 | 28.79M |
| June 30, 2020 | 17.16M |
| Date | Value |
|---|---|
| March 31, 2020 | 20.04M |
| December 31, 2019 | 15.22M |
| September 30, 2019 | 8.523M |
| June 30, 2019 | 6.956M |
| March 31, 2019 | 1.067M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.487M |
| June 30, 2018 | 0.487M |
| March 31, 2018 | 0.487M |
| June 30, 2017 | 0.487M |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Ocular Therapeutix, Inc. | 45.35M |
| Corcept Therapeutics, Inc. | 816.73M |
| Eli Lilly & Co. | 66.44B |
| Regeneron Pharmaceuticals, Inc. | 12.65B |
| Nuvation Bio, Inc. | 147.66M |